A Real-World Study of Safety, Immunogenicity and Efficacy of Bevacizumab in Patients with Solid

1. Abstract 1.1. Objective: The aim of this study was to evaluate the post-mar-keting safety, tolerability, immunogenicity and efficacy of Bevaci-zumab (manufactured by Hetero Biopharma) in a broader popula-tion of patients with solid tumors.